Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes

Overview of attention for article published in Diabetologia, March 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 92 Dimensions

Readers on

mendeley: 127 Mendeley
citeulike: 1 CiteULike

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes : Committee papers

Cited by National Institute for Health and Care Excellence on 17 Apr 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.